Gina Picchiarelli,Anne Wienand,Salim Megat,Amr Aly,Marije Been,Nibha Mishra,Saskia Hutten,Erin Sternburg,Pierre Cauchy,Stephane Dieterle,Marica Catinozzi,Valerie Demais,Laura Tzeplaeff,Annemarie Huebers,Dagmar Zeuschner,Angela Rosenbohm,Albert C Ludolph,Anne-Laurence Boutillier,Tobias Boeckers,Dorothee Dormann,Maria Demestre,Chantal Sellier,Clotilde Lagier-Tourenne,Erik Storkebaum,Luc Dupuis

Abstract:FUS is an RNA binding protein mutated in amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by progressive muscle weakness. We show that ALS-associated FUS mutations lead to ultrastructural defects in muscle of FUS-ALS patients, with disruption of sarcomeres and mitochondria. Studies in mouse and Drosophila models demonstrate an evolutionary-conserved cell autonomous function of FUS in muscle development. Mechanistically, FUS is required for transcription of MEF2 dependent genes, binds to the promoter of genes bound by ETS transcription factors in particular ETV5 and co-activates transcription of MEF2 dependent genes with ETV5. FUS phase separates with ETV5 and MEF2A, and MEF2A binding to FUS is potentiated by ETV5. Last, Etv5 haploinsufficiency exacerbates muscle weakness in a mouse model of FUS-ALS. These findings establish FUS as an essential protein for skeletal muscle structure through its phase separation-dependent recruitment of ETV5 and MEF2, defining a novel pathway compromised in FUS-ALS.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of FUS protein in muscle differentiation and structure, especially the recruitment mechanism of MEF2 and ETV5 mediated by liquid - liquid phase separation (LLPS). Specifically, the paper studied how FUS mutations related to amyotrophic lateral sclerosis (ALS) lead to ultrastructural defects in muscles, including the disruption of sarcomeres and mitochondria, and explored whether these defects are directly caused by the abnormal expression of FUS in muscle cells. The main findings of the paper include: 1. **Function of FUS in muscles**: FUS is crucial for the structure of skeletal muscles, and its dysfunction will lead to ultrastructural defects in sarcomeres and mitochondria. 2. **Molecular mechanism**: FUS participates in the regulation of MEF2 - dependent gene transcription through its interaction with MEF2 and ETV5. FUS co - localizes with ETV5 and forms phase separation, enhancing the transcriptional activation of target genes by MEF2. 3. **Cell autonomy**: In mouse and Drosophila models, muscle defects caused by FUS mutation or deletion are cell - autonomous, that is, these defects are directly caused by the abnormal expression of FUS in muscle cells. 4. **Clinical relevance**: Muscle biopsies from FUS - ALS patients and iPSC - derived myotubes show similar ultrastructural defects in sarcomeres and mitochondria, indicating that these defects are of great significance in human diseases. Through these studies, the paper reveals the crucial role of FUS in muscle development and maintenance, and proposes a new pathway, that is, FUS recruits MEF2 and ETV5 in a phase - separation - dependent manner to regulate the transcription of muscle genes, and this pathway is impaired in FUS - ALS.

FUS controls muscle differentiation and structure through LLPS mediated recruitment of MEF2 and ETV5